Zun-yi Zhang

发表

Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.

F. Liu, Yan-hui Wu, Shao-jun Zhou, 2014, Oncology reports.

Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report

Zun-yi Zhang, E. Zhang, Wei Zhang, 2021, World journal of clinical cases.

Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review

Bixiang Zhang, Zun-yi Zhang, E. Zhang, 2021, World journal of gastrointestinal surgery.

Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis.

Shao-jun Zhou, Zun-yi Zhang, E. Zhang, 2016, The Journal of surgical research.

Distilled Water Lavage During Surgery Improves Long-Term Outcomes of Patients with Ruptured Hepatocellular Carcinoma

Shao-jun Zhou, Zun-yi Zhang, E. Zhang, 2015, Journal of Gastrointestinal Surgery.

Complete Response Associated With Combination Treatment Regorafenib and Sintilimab in a Sorafenib-refractory Hepatocellular Carcinoma Patient

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2020 .

Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function.

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2016, Surgery.

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy

W. Lau, Zun-yi Zhang, E. Zhang, 2022, Journal of hepatocellular carcinoma.

Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2015, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma

Zun-yi Zhang, Wei Zhang, Wei-xun Chen, 2022, Frontiers in Pharmacology.

USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling

Jia Yu, Z. Liao, Zun-yi Zhang, 2022, Cell Death & Disease.

Predicting the severity of liver cirrhosis through clinical parameters.

J. Gu, Zun-yi Zhang, E. Zhang, 2016, The Journal of surgical research.

MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.

J. Gu, Zun-yi Zhang, E. Zhang, 2017, Oncology letters.

EXO1 Plays a Carcinogenic Role in Hepatocellular Carcinoma and is related to the regulation of FOXP3

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2020, Journal of Cancer.

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer

Yong-Jian Xu, Zun-yi Zhang, Shuang Wei, 2014, Oncotarget.

Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma

Z. Huang, X. Lv, Zun-yi Zhang, 2023, Frontiers in Immunology.

Complete Response to the Sequential Treatment with Regorafenib Followed by PD-1 Inhibitor in a Sorafenib-Refractory Hepatocellular Carcinoma Patient

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2020, OncoTargets and therapy.

Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2021, Scientific Reports.

Perioperative outcomes of robot-assisted versus laparoscopic liver resection for cavernous hemangioma: a propensity score matching study

Jun Liu, W. Lau, Bixiang Zhang, 2023, Surgical Endoscopy.

Acute portal vein thrombosis after hepatectomy in a patient with hepatolithiasis

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2018, Medicine.

Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis

Zun-yi Zhang, E. Zhang, Xiao-ping Chen, 2019, Medicine.

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review

Zun-yi Zhang, Xiao-ping Chen, Wei Zhang, 2023, Frontiers in Immunology.

Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review

Zun-yi Zhang, E. Zhang, 2023, Frontiers in Immunology.

Liver Collagen Contents Are Closely Associated with the Severity of Cirrhosis and Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma and Child–Pugh Grade A Liver Function

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2021, Annals of Surgical Oncology.

Use of Direct Liver Stiffness Measurement in Evaluating the Severity of Liver Cirrhosis in Patients with Hepatocellular Carcinoma

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2020, World Journal of Surgery.

Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertension.

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2019, Asian journal of surgery.

Scientific Hepatectomy for Hepatocellular Carcinoma

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2023, Current Medical Science.

Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2020, World Journal of Surgical Oncology.

Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells

Zun-yi Zhang, E. Zhang, Zhiyong Huang, 2015, Journal of Huazhong University of Science and Technology [Medical Sciences].

Case Report: Solitary metastasis to the appendix after curative treatment of HCC

Zun-yi Zhang, Yu-wei Wang, Wei Zhang, 2023, Frontiers in Surgery.